The Albert B. Sabin Vaccine Institute, Inc.
Budget
€56,335,448
EP Access
0
accredited persons
Staff
4
0.4 FTE
EU Grants
None
Mission & Goals
Sabin unlocks the full benefits of vaccines for everyone, everywhere, by harnessing the power of organizations and individuals rooted in communities. We develop novel vaccines, respond to outbreaks, fuel actionable research, champion data-driven advocacy, and strengthen local and national immunization leadership in low and middle-income (LMIC) countries. Our mission is singular: to advance vaccine access, drive innovation, and extend vaccination coverage to all.
EU Legislative Interests
Regulation (EU) 2022/2371
Communication Activities
This contract proposal is connected to Regulation (EU) 2022/2371, which established the European Health Emergency Response Authority (HERA), focusing on enhancing EU preparedness for health emergencies, including the procurement of medical countermeasures.
Interests Represented
Does not represent commercial interests
Member Of
Bay Area Global Health Alliance, Biopharmaceutical Manufacturing Preparedness Consortium, Global Health Council, Global Health Technologies Coalition, Medical CBRN Defense Consortium, Rapid Response Partnership Vehicle, Pan American Health Organization, World Health Organization
Organisation Members
Boost Community: https://www.sabin.org/global-immunization/boost-community/; Global HPV Consortium: https://www.sabin.org/global-immunization/the-global-hpv-consortium/
Commissioner Meetings
No recorded meetings with EU commissioners.